Bioequivalence Study Between Two Oral Formulations of Famotidine Tablets Under Fed Conditions

NCT00803192 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

44

Enrollment

INDUSTRY

Sponsor class

Conditions

Bioavailability

Interventions

DRUG: Famotidine Tablets, 40 mg

Sponsor

Perrigo Company